Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.
Rising incidence of multiple sclerosis in females associated with urbanization.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
[Emerging therapies for multiple sclerosis.]
Differential effect of baclofen on cortical and spinal inhibitory circuits.
Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
Neuroprotection With Phenytoin in Optic Neuritis
Involvement and interplay of Parkin, PINK1 and DJ1 in neurodegenerative and neuroinflammatory disorders.
Averting inflammation by targeting the cytokine environment.
Association between parasite infection and immune responses in multiple sclerosis.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Setting new standards in multiple sclerosis care and research.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.
Immunomodulatory properties of farnesoids: The new steroids?

Pages